Medrhythms Closes $25M Series B Funding Led By Morningside Ventures And Advantage Capital To Advance Digital Therapeutics Platform
Jul 28, 2021•almost 4 years ago
Amount Raised
$25 Million
Round Type
series b
Description
MedRhythms, a leader in developing prescription digital therapeutics that use sensors, software, and music to measure and improve walking for patients with a neurologic injury or disease, announced today the closing of a $25 million Series B financing round co-led by Morningside Ventures and Advantage Capital, with participation from existing investor Werth Family Investment Associates. The Company has raised a total of $34 million in gross proceeds from private financings since inception.
FundzWatch™ Score
78
Medium Activity
Buyer Intent Analysis
Get personalized insights on buying likelihood
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech